Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study).

Migliore, A; Bizzi, E; Massafra, U; Vacca, F; Martin Martin, L S; Ferlito, C; Podestà, E; Granata, M; Laganà, B

Migliore, A; Bizzi, E; Massafra, U; Vacca, F; Martin Martin, L S; Ferlito, C; Podestà, E; Granata, M; Laganà, B.

Affiliation

Migliore A; Operative Unit of Rheumatology, S.Pietro FBF Hospital, Rome, Italy.

Int J Immunopathol Pharmacol ; 23(3): 783-90, 2010.

Article in En | MEDLINE | ID: mdl-20943048

Subject(s)

Arthritis, Rheumatoid/drug therapy; Cyclosporine/therapeutic use; Immunosuppressive Agents/therapeutic use; Methotrexate/therapeutic use; Tumor Necrosis Factor Inhibitors; Adult; Aged; Arthritis, Rheumatoid/pathology; Blood Sedimentation; C-Reactive Protein/metabolism; Cyclosporine/adverse effects; Drug Combinations; Endpoint Determination; Female; Humans; Immunosuppressive Agents/adverse effects; Male; Methotrexate/adverse effects; Middle Aged; Pain/drug therapy; Pain/etiology; Pain Measurement; Prospective Studies; Recurrence

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Arthritis, Rheumatoid / Methotrexate / Cyclosporine / Tumor Necrosis Factor Inhibitors / Immunosuppressive Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2010 Type: Article

Search on Google

XML

PubMed Links